Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Lexeo Therapeutics (LXEO) Return on Capital Employed (2023 - 2026)

Lexeo Therapeutics' Return on Capital Employed history spans 1 years, with the latest figure at 85.61% for Q4 2023.

  • On a quarterly basis, Return on Capital Employed changed N/A to 85.61% in Q4 2023 year-over-year; TTM through Dec 2023 was 85.61%, a N/A change, with the full-year FY2023 number at 67.7%, changed N/A from a year prior.
  • Return on Capital Employed hit 85.61% in Q4 2023 for Lexeo Therapeutics.
  • Over the last five years, Return on Capital Employed for LXEO hit a ceiling of 85.61% in Q4 2023 and a floor of 85.61% in Q4 2023.